Regulation 216 Amendment of Schedule 30 (particulars for advertisements to persons qualified to prescribe or supply)I1F1

in paragraphs 1, 2 and 6, for “marketing authorisation,” substitute “UK marketing authorisation, EU marketing authorisation”;

after paragraph 2 insert—

“2A.

In relation to an advertisement in Great Britain (other than an advertisement falling within the exception in regulation 296) where the medicinal product concerned is authorised under a UKMA(GB), a statement that the product concerned is authorised under a UKMA(GB).”.